Why Full Spectrum CBD Products Are Superior to Those Having Isolates

November 14, 2019 16:00:51

Over the years, there have been very few medicines that have proven as potent and versatile as cannabidiol (CBD) has. The extract is one of the over 100 active components that occur naturally in the cannabis plants, and its medicinal qualities have taken the world by storm. Said to be effective against a host of diseases ranging from anxiety, high blood pressure, and depression to rare childhood epilepsies, CBD, and hemp by extension, has enjoyed significant booms in both demand and supply.

This was compounded by the 2018 Farm Bill, which legalized the cultivation of industrial hemp. In October, the USDA released further regulations to structure the sector, making it easier for hemp farmers and CBD processors to run their operations. This has resulted in an influx of CBD products, each claiming to be medically effective. Most of these products contain either CBD isolate or full-spectrum CBD, but the question is, which of the two is more effective?

CBD isolate, often referred to as CBD crystals, is white, crystalline powder. It is the purest form of naturally occurring cannabidiol, often containing up to 99.9 percent CBD. It is made from filtered hemp plant, and the resultant CBD crystals are crushed into a fine powder for easy use. Full Spectrum CBD, on the other hand, contains not only cannabidiol but other essential aromatic compounds and traces of additional cannabinoids. Of the two, full-spectrum cannabidiol is more likely to be more effective.

This is the result of what has been termed the ‘entourage effect.’ While the isolate contains CBD alone, full-spectrum CBD contains varied, naturally occurring ingredients that, when combined, amplify cannabidiol’s effect on the body. CBD gummy bears, for instance, have become extremely popular. In 2018, it was the third most searched food on Google. Each gummy bear has 20mg of cannabidiol, but most consumers have found that they have to eat more of the isolate derived gummy bears to get the desired effect.

It’s the difference between one lone strong fighter, and one strong fighter flanked by a couple of partners. Full-spectrum CBD has support from flavonoids, terpenes, and low levels of other cannabinoids such as CBN, CBDV, THCV, CBG, CBDA, CBC, and THCA. Together with the high CBD levels, they achieve a sort of synergy that makes full-spectrum CBD derived products a lot more potent and effective. For that reason, be sure to consult a doctor before using any sort of CBD-infused product for medical reasons.

Industry insiders say reputable CBD companies like Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and MCTC Holdings Inc. (OTC: MCTC) always educate their clients about the differences between those forms of CBD so that buyers can make informed decisions.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.